Mobile Stroke Treatment Unit Feasible for Acute Stroke Care

This article originally appeared here.
Share this content:
Mobile Stroke Treatment Unit Feasible for Acute Stroke Care
Mobile Stroke Treatment Unit Feasible for Acute Stroke Care

TUESDAY, Dec. 8, 2015 (HealthDay News) -- A mobile stroke treatment unit (MSTU) is feasible for providing acute stroke treatment, according to a study published online Dec. 7 in JAMA Neurology.

In a prospective observational cohort study, Ahmed Itrat, M.D., from the Cleveland Clinic, and colleagues examined whether telemedicine is reliable and remote physician presence is adequate for acute stroke treatment using an MSTU. Participants were 100 residents of Cleveland with an acute onset of stroke-like symptoms who were evaluated by the MSTU. The patients were evaluated by a vascular neurologist via telemedicine; a neuroradiologist remotely assessed images obtained by mobile computed tomography.

Ninety-nine of the patients were successfully assessed, with a median duration of assessment of 20 minutes. The researchers found that there was one connection failure due to crew error; the patient was transported to the emergency department. Six telemedicine disconnections occurred, none of which lasted for more than 60 seconds or impacted clinical care. The times from door to CT completion and from door to intravenous thrombolysis were 13 and 32 minutes, respectively, in the MSTU group, which were significantly shorter than in the control group (18 and 58 minutes, respectively). There was no between-group difference noted in times to CT interpretation.

"An MSTU using telemedicine is feasible, with a low rate of technical failure, and may provide an avenue for reducing the high cost of such systems," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin

More Evidence HPV Vaccine Protects Against Cervical Cancer

More Evidence HPV Vaccine Protects Against Cervical Cancer

Protection appears to occur even when only one or two of the recommended doses are given

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Study of millions of health records suggests an association

is free, fast, and customized just for you!

Already a member?

Sign In Now »